BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali A, Black D, Soslow RA. Difficulties in Assessing the Depth of Myometrial Invasion in Endometrial Carcinoma: . International Journal of Gynecological Pathology 2007;26:115-23. [DOI: 10.1097/01.pgp.0000233165.56385.0b] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Matias-guiu X, Selinger CI, Anderson L, Buza N, Ellenson LH, Fadare O, Ganesan R, Ip PP, Palacios J, Parra-herran C, Raspollini MR, Soslow RA, Werner HM, Lax SF, Mccluggage WG. Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology 2022;41:S90-S118. [DOI: 10.1097/pgp.0000000000000901] [Reference Citation Analysis]
2 Bian P, Liu S, Luo Q, Xiong Z. YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia. Pathology - Research and Practice 2022;234:153919. [DOI: 10.1016/j.prp.2022.153919] [Reference Citation Analysis]
3 Dokter E, Anderson L, Cho SM, Cohen-Hallaleh V, Lam KM, Saidi SA, Kitzing YX. Radiology-pathology correlation of endometrial carcinoma assessment on magnetic resonance imaging. Insights Imaging 2022;13:80. [PMID: 35467253 DOI: 10.1186/s13244-022-01218-3] [Reference Citation Analysis]
4 Cui T, Shi F, Gu B, Jin Y, Guo J, Zhang C, Ren J, Yue Y. Peritumoral Enhancement for the Evaluation of Myometrial Invasion in Low-Risk Endometrial Carcinoma on Dynamic Contrast-Enhanced MRI. Front Oncol 2022;11:793709. [DOI: 10.3389/fonc.2021.793709] [Reference Citation Analysis]
5 Dybvik JA, Fasmer KE, Ytre-Hauge S, Husby JHA, Salvesen ØO, Stefansson IM, Krakstad C, Trovik J, Haldorsen IS. MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. Insights Imaging 2022;13:1. [PMID: 35000020 DOI: 10.1186/s13244-021-01133-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Husain S. Epithelial Tumors and Precursors, Type 1. Encyclopedia of Pathology 2022. [DOI: 10.1007/978-3-319-28845-1_5624-1] [Reference Citation Analysis]
7 Gao H, Chen C, Mao W, Weng W, Li Z, Lin Y. A feasible method to determine the depth of myometrial invasion of endometrial carcinoma based on improved thinning algorithm. 2021 11th International Conference on Information Technology in Medicine and Education (ITME) 2021. [DOI: 10.1109/itme53901.2021.00085] [Reference Citation Analysis]
8 Mateva S, Nikolova M, Yordanov A. Patterns of Myometrial Invasion in Endometrial Adenocarcinoma with Emphasizing on Microcystic, Elongated and Fragmented (MELF) Glands Pattern: A Narrative Review of the Literature. Diagnostics (Basel) 2021;11:1707. [PMID: 34574048 DOI: 10.3390/diagnostics11091707] [Reference Citation Analysis]
9 Giustozzi A, Salutari V, Giudice E, Musacchio L, Ricci C, Landolfo C, Perri MT, Scambia G, Lorusso D. Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives. Biology (Basel) 2021;10:845. [PMID: 34571723 DOI: 10.3390/biology10090845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Just PA, Moret S, Borghese B, Chapron C. [Endometriosis and adenomyosis]. Ann Pathol 2021:S0242-6498(21)00086-9. [PMID: 34183193 DOI: 10.1016/j.annpat.2021.03.012] [Reference Citation Analysis]
11 Zhang Y, Jeyachandran D, Desouki MM. Grossly unremarkable cervix in endometrial carcinomas: lymphovascular space invasion and microcystic elongated and fragmented pattern may be associated with high incidence of cervical stromal involvement. Hum Pathol 2021;113:59-66. [PMID: 33933559 DOI: 10.1016/j.humpath.2021.04.011] [Reference Citation Analysis]
12 Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Martin AG, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol 2021;154:327-53. [PMID: 33712263 DOI: 10.1016/j.radonc.2020.11.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 32.0] [Reference Citation Analysis]
13 Rodríguez-Martínez A, Trapero C, Vidal A, Piulats JM, Gómez de Aranda I, Sévigny J, Fernández-Montolí ME, Ponce J, Matias-Guiu X, Martín-Satué M. Characterization of the Endometrial MSC Marker Ectonucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2/CD39L1) in Low- and High-Grade Endometrial Carcinomas: Loss of Stromal Expression in the Invasive Phenotypes. J Pers Med 2021;11:331. [PMID: 33922226 DOI: 10.3390/jpm11050331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann JA, Bosse T, Chargari C, Fagotti A, Fotopoulou C, González-Martín A, Lax SF, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell DE, Querleu D, Raspollini MR, Sehouli J, Sturdza AE, Taylor A, Westermann AM, Wimberger P, Colombo N, Planchamp F, Matias-Guiu X. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma. Virchows Arch 2021;478:153-90. [PMID: 33604759 DOI: 10.1007/s00428-020-03007-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 29.0] [Reference Citation Analysis]
15 Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021;31:12-39. [PMID: 33397713 DOI: 10.1136/ijgc-2020-002230] [Cited by in Crossref: 327] [Cited by in F6Publishing: 329] [Article Influence: 163.5] [Reference Citation Analysis]
16 An M, Duan H, Zhang Y. Prognostic significance of co‐existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta‐analysis. J Obstet Gynaecol Res 2020;46:1851-63. [DOI: 10.1111/jog.14371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ireland-Jenkin K, Selinger C, Newman M. Highlighted issues from the second edition RCPA Endometrial Cancer Structured Reporting Protocol. Pathology 2020;52:293-6. [PMID: 32113674 DOI: 10.1016/j.pathol.2020.02.001] [Reference Citation Analysis]
18 Matias-guiu X, Parra-herran C. Endometrial Glandular Neoplasia. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00010-2] [Reference Citation Analysis]
19 Horn LC, Emons G, Aretz S, Bock N, Follmann M, Lax S, Nothacker M, Steiner E, Mayr D; Deutsche Krebsgesellschaft (DKG)., Kommission zur Erstellung der S3-Leitlinie „Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom“. [S3 guidelines on the diagnosis and treatment of carcinoma of the endometrium : Requirements for pathology]. Pathologe 2019;40:21-35. [PMID: 30756154 DOI: 10.1007/s00292-019-0574-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Khalifa MA, Atri M, Klein ME, Ghatak S, Murugan P. Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging. Semin Ultrasound CT MR 2019;40:358-63. [PMID: 31375175 DOI: 10.1053/j.sult.2019.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
21 Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E. Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). Int J Gynecol Pathol 2019;38 Suppl 1:S93-S113. [PMID: 30550486 DOI: 10.1097/PGP.0000000000000524] [Cited by in Crossref: 61] [Cited by in F6Publishing: 71] [Article Influence: 20.3] [Reference Citation Analysis]
22 Eriksson LSE, Nastic D, Frühauf F, Fischerova D, Nemejcova K, Bono F, Franchi D, Fruscio R, Ghioni M, Haak LA, Hejda V, Meskauskas R, Opolskiene G, Pascual MA, Testa A, Tresserra F, Zannoni GF, Carlson JW, Epstein E. Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria. Int J Gynecol Cancer 2019;29:119-25. [DOI: 10.1136/ijgc-2018-000045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mills AM. Endometrial Carcinoma. Gynecologic and Obstetric Pathology, Volume 1 2019. [DOI: 10.1007/978-981-13-3016-2_18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Steiner E, Horn L, Menke J, Mayr D, Lax S, Cremer W, Prömpeler H, Reinhardt M. Früherkennung, Diagnostik, Bildgebung und Pathologie des Endometriumkarzinoms. Gynäkologe 2018;51:1009-1017. [DOI: 10.1007/s00129-018-4335-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Kawaguchi M, Kato H, Hatano Y, Mizuno N, Furui T, Morishige K, Hara A, Goshima S, Matsuo M. Inchworm sign of endometrial cancer on diffusion-weighted MRI: radiology-pathology correlation. Clin Radiol 2018;73:907.e9-907.e14. [PMID: 29895387 DOI: 10.1016/j.crad.2018.05.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Whittle R, Peat G, Belcher J, Collins GS, Riley RD. Measurement error and timing of predictor values for multivariable risk prediction models are poorly reported. J Clin Epidemiol 2018;102:38-49. [PMID: 29782997 DOI: 10.1016/j.jclinepi.2018.05.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
27 Doghri R, Chaabouni S, Houcine Y, Charfi L, Boujelbene N, Driss M, Mrad K. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer. Mol Clin Oncol 2018;9:87-91. [PMID: 29896403 DOI: 10.3892/mco.2018.1629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
28 McCluggage WG. Pathologic Staging of Endometrial Carcinomas: Selected Areas of Difficulty. Adv Anat Pathol 2018;25:71-84. [PMID: 29356713 DOI: 10.1097/PAP.0000000000000182] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
29 Horn L, Höhn AK. Processing and Histopathological Workup of Hysterectomy Specimens. Hysterectomy 2018. [DOI: 10.1007/978-3-319-22497-8_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Lax SF. Pathology of Endometrial Carcinoma. Adv Exp Med Biol 2017;943:75-96. [PMID: 27910065 DOI: 10.1007/978-3-319-43139-0_3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 7.2] [Reference Citation Analysis]
31 Naki MM, Oran G, Tetikkurt SÜ, Sönmez CF, Türkmen İ, Köse F. Microcystic, elongated, and fragmented pattern of invasion in relation to histopathologic and clinical prognostic factors in endometrioid endometrial adenocarcinoma. J Turk Ger Gynecol Assoc 2017;18:139-42. [PMID: 28890428 DOI: 10.4274/jtgga.2017.0016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Jeffreys MA, Laury AR, Quick CM. Diagnostic dilemmas and potential pitfalls in the evaluation of endometrial adenocarcinoma. Diagnostic Histopathology 2017;23:323-330. [DOI: 10.1016/j.mpdhp.2017.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Lax SF. Classification of Endometrial Carcinoma. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_2] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Bourgioti C, Chatoupis K, Tzavara C, Antoniou A, Rodolakis A, Moulopoulos LA. Predictive ability of maximal tumor diameter on MRI for high-risk endometrial cancer. Abdom Radiol (NY) 2016;41:2484-95. [PMID: 27714421 DOI: 10.1007/s00261-016-0927-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
35 van der Putten LJ, van de Vijver K, Bartosch C, Davidson B, Gatius S, Matias-Guiu X, McCluggage WG, Toledo G, van der Wurff AA, Pijnenborg JM, Massuger LF, Bulten J. Reproducibility of measurement of myometrial invasion in endometrial carcinoma. Virchows Arch 2017;470:63-8. [PMID: 27787595 DOI: 10.1007/s00428-016-2035-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
36 Soslow RA. Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome. Mod Pathol 2016;29 Suppl 1:S59-77. [PMID: 26715174 DOI: 10.1038/modpathol.2015.127] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
37 Selove W, Bradford LS, Liu Y. Assessing Residents’ Frozen Section Skills for Endometrial Cancer: . International Journal of Gynecological Pathology 2016;35:402-9. [DOI: 10.1097/pgp.0000000000000247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Lobo FD, Thomas E. Type II endometrial cancers: A case series. J Midlife Health 2016;7:69-72. [PMID: 27499593 DOI: 10.4103/0976-7800.185335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
39 Busca A, Djordjevic B, Giassi A, Parra-Herran C. IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma. Am J Clin Pathol 2016;145:486-96. [PMID: 27124937 DOI: 10.1093/ajcp/aqw021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
40 Habiba M, Benagiano G. Adenomyosis and Endometrial Carcinoma. Uterine Adenomyosis 2016. [DOI: 10.1007/978-3-319-13012-5_10] [Reference Citation Analysis]
41 Baker PM, Oliva E. Prognostic Factors in Uterine Cancer. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_4] [Reference Citation Analysis]
42 Dogan Altunpulluk M, Kir G, Topal CS, Cetiner H, Gocmen A. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis. Journal of Obstetrics and Gynaecology 2014;35:397-402. [DOI: 10.3109/01443615.2014.960827] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
43 Han G, Lim D, Leitao MM Jr, Abu-Rustum NR, Soslow RA. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma. Histopathology 2014;64:389-98. [PMID: 24215212 DOI: 10.1111/his.12254] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
44 Laury AR, Quick CM. Diagnostic dilemmas and potential pitfalls in the evaluation of endometrial adenocarcinoma. Diagnostic Histopathology 2013;19:238-44. [DOI: 10.1016/j.mpdhp.2013.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Hirschowitz L, Nucci M, Zaino RJ. Problematic issues in the staging of endometrial, cervical and vulval carcinomas. Histopathology 2013;62:176-202. [PMID: 23240675 DOI: 10.1111/his.12058] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
46 Chattopadhyay S, Cross P, Nayar A, Galaal K, Naik R. Tumor Size: A Better Independent Predictor of Distant Failure and Death Than Depth of Myometrial Invasion in International Federation of Gynecology and Obstetrics Stage I Endometrioid Endometrial Cancer. International Journal of Gynecological Cancer 2013;23:690-7. [DOI: 10.1097/igc.0b013e31828c85c6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
47 Cole AJ, Quick CM. Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications. Adv Anat Pathol 2013;20:141-7. [PMID: 23574770 DOI: 10.1097/PAP.0b013e31828d17cc] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
48 Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Massuger LF. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Gynecol Oncol 2013;129:285-91. [PMID: 23422503 DOI: 10.1016/j.ygyno.2013.02.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
49 Mccluggage WG, Colgan T, Duggan M, Hacker NF, Mulvany N, Otis C, Wilkinson N, Zaino RJ, Hirschowitz L. Data Set for Reporting of Endometrial Carcinomas: Recommendations From the International Collaboration on Cancer Reporting (ICCR) Between United Kingdom, United States, Canada, and Australasia. International Journal of Gynecological Pathology 2013;32:45-65. [DOI: 10.1097/pgp.0b013e31825d808b] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
50 Lax S. Erkrankungen des Endometriums. Pathologie 2013. [DOI: 10.1007/978-3-642-04564-6_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Lax S. Erkrankungen des Myometriums. Pathologie 2013. [DOI: 10.1007/978-3-642-04564-6_20] [Reference Citation Analysis]
52 Cole L, Stoler MH. Issues and inconsistencies in the revised gynecologic staging systems. Seminars in Diagnostic Pathology 2012;29:167-73. [DOI: 10.1053/j.semdp.2011.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
53 Chattopadhyay S, Galaal KA, Patel A, Fisher A, Nayar A, Cross P, Naik R. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer. BJOG 2012;119:1162-70. [PMID: 22804815 DOI: 10.1111/j.1471-0528.2012.03427.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
54 Endometrioid adenocarcinoma. Uterine Pathology 2012. [DOI: 10.1017/cbo9780511978104.008] [Reference Citation Analysis]
55 Clarke BA, Mulligan AM, Irving JA, McCluggage WG, Oliva E. Müllerian adenosarcomas with unusual growth patterns: staging issues. Int J Gynecol Pathol 2011;30:340-7. [PMID: 21623203 DOI: 10.1097/PGP.0b013e31820b341e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
56 Stewart CJR, Crook ML, Lacey J, Louwen K. Cytokeratin 19 Expression in Normal Endometrium and in Low-grade Endometrioid Adenocarcinoma of the Endometrium: . International Journal of Gynecological Pathology 2011;30:484-91. [DOI: 10.1097/pgp.0b013e3182158944] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
57 Shin KE, Park BK, Kim CK, Bae DS, Song SY, Kim B. MR staging accuracy for endometrial cancer based on the new FIGO stage. Acta Radiol 2011;52:818-24. [PMID: 21742787 DOI: 10.1258/ar.2011.100426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
58 Kondalsamy-Chennakesavan S, van Vugt S, Sanday K, Nicklin J, Land R, Perrin L, Crandon A, Obermair A. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Int J Gynecol Cancer 2010;20:1217-21. [PMID: 21495232 DOI: 10.1111/igc.0b013e3181ef0a31] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
59 Zaloudek CJ, Hendrickson MR, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s Pathology of the Female Genital Tract. Boston: Springer US; 2011. pp. 453-527. [DOI: 10.1007/978-1-4419-0489-8_10] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
60 Ellenson LH, Ronnett BM, Soslow RA, Zaino RJ, Kurman RJ. Endometrial Carcinoma. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s Pathology of the Female Genital Tract. Boston: Springer US; 2011. pp. 394-452. [DOI: 10.1007/978-1-4419-0489-8_9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
61 Azueta A, Gatius S, Matias-guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features. Seminars in Diagnostic Pathology 2010;27:226-40. [DOI: 10.1053/j.semdp.2010.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
62 Hanley KZ, Dustin SM, Stoler MH, Atkins KA. The Significance of Tumor Involved Adenomyosis in Otherwise Low-stage Endometrioid Adenocarcinoma: . International Journal of Gynecological Pathology 2010;29:445-51. [DOI: 10.1097/pgp.0b013e3181d81de6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
63 Stewart CJR, Crook ML, Doherty DA. Micro-anatomical variation in cellular proliferation in endometrial adenocarcinoma, and inverse correlation between Ki67 and cytokeratin 7 expression: Endometrial carcinoma proliferation. Histopathology 2010;57:46-54. [DOI: 10.1111/j.1365-2559.2010.03588.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
64 Rabban JT, Soslow RA, Zaloudek CZ. Immunohistology of the Female Genital Tract. Diagnostic Immunohistochemistry. Elsevier; 2010. pp. 690-762. [DOI: 10.1016/b978-1-4160-5766-6.00022-4] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
65 Mccluggage WG. Problematic areas in the reporting of endometrial carcinomas in hysterectomy specimens. Diagnostic Histopathology 2009;15:571-81. [DOI: 10.1016/j.mpdhp.2009.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
66 Stewart C, Brennan B, Leung Y, Little L. MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion. Pathology 2009;41:454-9. [DOI: 10.1080/00313020903041135] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
67 Stewart CJR, Little L. Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition. Histopathology 2009;55:91-101. [DOI: 10.1111/j.1365-2559.2009.03327.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
68 Zaino RJ. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol 2009;28:1-9. [PMID: 19047915 DOI: 10.1097/PGP.0b013e3181846c6d] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 6.5] [Reference Citation Analysis]
69 Schwab KV, O'Malley DM, Fowler JM, Copeland LJ, Cohn DE. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. Gynecol Oncol 2009;112:146-9. [PMID: 18937970 DOI: 10.1016/j.ygyno.2008.09.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
70 Clement PB, Young RH. Endometrial Hyperplasia and Carcinoma. Atlas of Gynecologic Surgical Pathology 2008. [DOI: 10.1016/b978-1-4160-2972-4.50012-x] [Reference Citation Analysis]
71 Kwon JS, Francis JA, Qiu F, Weir MM, Ettler HC. When Is a Pathology Review Indicated in Endometrial Cancer? Obstetrics & Gynecology 2007;110:1224-30. [DOI: 10.1097/01.aog.0000287618.86078.6c] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]